DexCom, Inc.

DXCM

$79.58

Name : DexCom, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $29,677,568,000.00

EPSttm : 2.54

DexCom, Inc.

$79.58

0.43%

$0.345

DXCM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.28

Margin Of Safety %

Put/Call OI Ratio

0.96

EPS Next Q Diff

-0.09

EPS Last/This Y

0.61

EPS This/Next Y

0.43

Price

79.9

Target Price

99.36

Analyst Recom

1.39

Performance Q

-11.98

Upside

11.7%

Beta

1.44

Ticker: DXCM

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	DXCM	85.93	0.91	0.60	79133
2026-10-13	DXCM	85.06	0.90	1.46	79920
2026-10-14	DXCM	83.48	0.90	3.94	80878
2026-10-15	DXCM	87.71	0.93	0.34	82972
2026-10-16	DXCM	86.05	0.89	0.58	87228
2026-10-19	DXCM	85.96	0.89	0.21	83368
2026-10-20	DXCM	85.76	0.88	1.34	83941
2026-10-21	DXCM	80.26	0.89	0.49	84665
2026-10-22	DXCM	78.34	0.89	1.75	86217
2026-10-23	DXCM	77.93	0.90	0.50	87085
2026-10-26	DXCM	78.55	0.92	0.17	84610
2026-10-27	DXCM	78.56	0.91	2.76	85834
2026-10-28	DXCM	78.58	0.93	1.19	88856
2026-10-29	DXCM	79.89	0.95	0.87	90010
2026-10-30	DXCM	82.3	0.95	0.41	95482
2026-11-02	DXCM	84.77	0.97	0.24	87672
2026-11-03	DXCM	82.89	0.96	1.03	88971
2026-11-04	DXCM	88.47	0.96	0.61	91053
2026-11-05	DXCM	84.47	0.96	0.31	92328
2026-11-06	DXCM	79.39	0.93	0.59	94515
2026-11-09	DXCM	81.05	0.96	0.92	91201
2026-11-10	DXCM	79.92	0.96	0.19	91588
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	DXCM	85.92	10.4	-58.5	2.66
2026-10-13	DXCM	85.10	10.4	-96.8	2.66
2026-10-14	DXCM	83.49	10.4	-107.5	2.66
2026-10-15	DXCM	87.71	10.5	-46.3	2.66
2026-10-16	DXCM	86.06	10.5	-107.9	2.66
2026-10-19	DXCM	85.95	10.5	-86.3	2.66
2026-10-20	DXCM	85.95	10.5	-86.3	2.66
2026-10-21	DXCM	85.76	10.5	-88.0	2.66
2026-10-22	DXCM	78.33	10.5	-114.7	2.66
2026-10-23	DXCM	77.93	10.5	-91.3	2.66
2026-10-26	DXCM	78.55	10.5	-75.4	2.66
2026-10-27	DXCM	78.57	10.5	-85.9	2.66
2026-10-28	DXCM	78.62	10.5	-84.1	2.66
2026-10-29	DXCM	79.93	10.5	-64.5	2.66
2026-10-30	DXCM	82.30	10.5	-48.5	2.66
2026-11-02	DXCM	84.76	10.5	-29.4	2.66
2026-11-03	DXCM	82.97	5.4	-55.6	2.70
2026-11-04	DXCM	88.47	5.4	15.5	2.70
2026-11-05	DXCM	84.46	5.4	-121.4	2.70
2026-11-06	DXCM	79.40	5.4	-23.7	2.70
2026-11-09	DXCM	81.05	5.4	85.1	2.70
2026-11-10	DXCM	79.90	5.4	37.7	2.70
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	DXCM	-2.41	1.03	3.78
2026-10-13	DXCM	-2.41	1.03	3.78
2026-10-14	DXCM	-2.41	1.03	3.78
2026-10-15	DXCM	-2.41	1.03	3.78
2026-10-16	DXCM	-2.41	1.03	3.78
2026-10-19	DXCM	-2.39	0.79	3.78
2026-10-20	DXCM	-2.41	0.79	3.78
2026-10-21	DXCM	-2.41	0.79	3.78
2026-10-22	DXCM	-2.41	0.79	3.78
2026-10-23	DXCM	-2.41	0.79	3.78
2026-10-26	DXCM	-2.41	0.97	3.78
2026-10-27	DXCM	-2.41	0.97	4.23
2026-10-28	DXCM	-2.41	0.97	4.23
2026-10-29	DXCM	-2.45	0.97	4.23
2026-10-30	DXCM	-2.45	0.97	4.23
2026-11-02	DXCM	-2.48	0.15	4.28
2026-11-03	DXCM	-2.48	0.15	4.28
2026-11-05	DXCM	-2.48	0.15	4.28
2026-11-06	DXCM	-2.48	0.15	4.28
2026-11-09	DXCM	-2.48	1.04	4.28
2026-11-10	DXCM	-2.48	1.04	4.28
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.73

Avg. EPS Est. Current Quarter

0.72

Avg. EPS Est. Next Quarter

0.64

Insider Transactions

-2.48

Institutional Transactions

1.04

Beta

1.44

Average Sales Estimate Current Quarter

1384

Average Sales Estimate Next Quarter

1312

Fair Value

80.37

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

51.5

Max Drawdown 5-Year %

-66.3

Target Price

99.36

P/E

31.32

Forward P/E

25.43

PEG

1.21

P/S

5.84

P/B

11.76

P/Free Cash Flow

27.14

EPS

2.55

Average EPS Est. Cur. Y

2.7

EPS Next Y. (Est.)

3.13

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.41

Relative Volume

0.7

Return on Equity vs Sector %

12.8

Return on Equity vs Industry %

28.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

37.7

◆ DXCM Healthcare

$79.92

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

19/25

Volume

6/15

Valuation

18/20

TP/AR

4/10

Options

4/10

RSI

44.2

Range 1M

24.5%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

21/30

Estimates

8/20

Inst/Vol

4/15

Options

7/10

EPS Yr

29.3%

EPS NY

16.3%

52W%

65.4%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟡 HOLD +23.6% upside

Quality

30/30

Valuation

12/30

Growth

17/25

Stability

6/10

LT Trend

1/5

Upside

+23.6%

Quality

MoS

DXCM — P/E HistoricalDiagnostics & Research

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 11000

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

DXCM

Latest News

—

Caricamento notizie per DXCM…

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y